Balyasny Asset Management LLC Biogen Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 6,400 shares of BIIB stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,400

Previous 394,887 98.38%

Holding current value

$1.02 Million

Previous $91.5 Million 98.65%

% of portfolio

0.0%

Previous 0.17%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $75.2 Million - $93.5 Million	394,887 New	394,887 $91.5 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $19.3 Million - $23.3 Million	86,891 Added 37.71%	317,302 $82.1 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $43.2 Million - $48.7 Million	170,423 Added 284.1%	230,411 $59.2 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $49.4 Million - $57.1 Million	-179,407 Reduced 74.94%	59,988 $17.1 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $48.2 Million - $55 Million	188,012 Added 365.9%	239,395 $66.6 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $31.5 Million - $38.3 Million	-124,782 Reduced 70.83%	51,383 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $29.8 Million - $41 Million	152,859 Added 655.88%	176,165 $47 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $27.2 Million - $32.3 Million	-144,870 Reduced 86.14%	23,306 $4.75 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $16.8 Million - $21.2 Million	86,932 Added 107.0%	168,176 $35.4 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $7.77 Million - $9.99 Million	34,709 Added 74.59%	81,244 $19.5 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $26 Million - $33.9 Million	-91,744 Reduced 66.35%	46,535 $13.2 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $12.6 Million - $20.2 Million	48,659 Added 54.29%	138,279 $47.9 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $13.2 Million - $15.5 Million	54,485 Added 155.07%	89,620 $25.1 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $27.9 Million - $42 Million	-118,123 Reduced 77.07%	35,135 $8.6 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $6.25 Million - $7.21 Million	23,589 Added 18.19%	153,258 $43.5 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $25.5 Million - $35.2 Million	115,873 Added 839.9%	129,669 $38.5 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $23.2 Million - $26 Million	-106,661 Reduced 88.55%	13,796 $3.21 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $21.3 Million - $23.5 Million	97,034 Added 414.27%	120,457 $28.2 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $18 Million - $28.2 Million	-83,143 Reduced 78.02%	23,423 $5.54 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $27.9 Million - $35.3 Million	100,039 Added 1532.69%	106,566 $32.1 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $11.5 Million - $15 Million	-39,178 Reduced 85.72%	6,527 $2.31 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $102 Million - $121 Million	-394,455 Reduced 89.62%	45,705 $13.3 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $28 Million - $39.5 Million	-107,449 Reduced 19.62%	440,160 $121 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $118 Million - $133 Million	385,130 Added 237.03%	547,609 $174 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $45.7 Million - $53.6 Million	162,479	162,479 $50.9 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Biogen Inc. Transaction History